Form 4 for NBP NovaBridge Biosciences
Accepted 2026-04-28 16:05:04 ET · period of report 2026-04-24 · accession 0001193125-26-186924 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 16:05 | 2026-04-24 | NBP | Hagler Mark Arnold | See Remarks | P - Purchase | $2.51 | +230.0K | 230.0K | New | +$577.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-04-24 | P | A | 230,000 | $2.51 | 230,000 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. (F2) The reported securities are represented by 100,000 ADSs. (F3) The price reported in Column 4 is a weighted average price. These ADSs were purchased in multiple transactions at prices ranging from $2.44 to $2.54, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) The reported securities are represented by 100,000 ADSs. |